Ryanodine receptors

Cell Calcium

Volumn 38, Issue 3-4 SPEC. ISS., 2005, Pages 253-260

  Hamilton, Susan L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; ISOPROTEIN; RYANODINE RECEPTOR; TETRAMER;

CELL ACTIVATION; CELL COMMUNICATION; CELL MEMBRANE; CELLULAR DISTRIBUTION; CHEMOSENSITIVITY; CYTOPLASM; GENE MUTATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE TACHYCARDIA; HUMAN; MALIGNANT HYPERTHERMIA; MUTAGENESIS; MYOPATHY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW;

EID: 24644455527     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceca.2005.06.037     Document Type: Article

References (91)

1. G. Meissner Regulation of mammalian ryanodine receptors Front. Biosci. 7 2002 d2072-d2080
2. V. Sorrentino P. Volpe Ryanodine receptors: How many, where and why? Trends Pharmacol. Sci. 14 3 1993 98-103
3. 2+ channels J. Biol Chem. 273 22 1998 13403-13406
4. C.F. Perez S. Mukherjee P.D. Allen Amino acids 1-1680 of ryanodine receptor type 1 hold critical determinants of skeletal type for excitation-contraction coupling. Role of divergence domain D2 J. Biol. Chem. 278 41 2003 39644-39652
5. 2+) release channel (ryanodine receptor) J. Biol. Chem. 275 16 2000 11778-11783
6. 2+) release channel FEBS Lett. 461 3 1999 157-164
7. J. Fujii K. Otsu F. Zorzato S. DeLeon V.K. Khanna J.E. Weiler P.J. O'Brien D.H. MacLennan Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia Science 253 1991 448-451
8. K.A. Quane J.M.S. Healy K.E. Keating B.M. Manning F.J. Couch L.M. Palmucci C. Doriguzzi T.H. Fagerlund K. Berg H. Ording D. Bendixen W. Mortier U. Linz C.R. Muller T.V. McCarthy Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia Nat. Genet. 5 1993 51-55
9. M.S. Phillips V.K. Khana S. De Leon W. Frodis B.A. Britt D.H. MacLennan The substitution of Arg for Gly2433 in the human skeletal muscle ryanodine receptor is associated with malignant hyperthermia Hum. Mol. Genet. 3 12 1994 2181-2186
10. Y. Zhang H.S. Chen V.K. Khanna S. DeLeon M.S. Phillips K. Schappert B.A. Britt A.K. Brownell D.H. MacLennan A mutation in the human ryanodine receptor gene associated with central core disease Nat. Genet. 5 1993 46-50
11. K.A. Quane K.E. Keating J.M. Healy B.M. Manning R. Krivosic-Horber I. Krivosic N. Monnier J. Lunardi T.V. McCarthy Mutation screening of the RYR1 gene in malignant hypertherima: Detection of a novel Tyr to Ser mutation in a pedigree with associated central core Genomics 23 1 1994 236-239
12. G.M. Shy K.R. Magee A new congenital non-progressive myopathy Brain 79 1956 610-621
13. W. Engel J. Foster B. Hughes H. Huxley R. Mahler Central core disease - an investigation of a rare muscle cell abnormality Brain 84 1961 167-185
14. 2+ release channels J. Biol. Chem. 274 2 1999 693-702
15. N. Tilgen F. Zorzato B. Halliger-Keller F. Muntoni C. Sewry L.M. Palmucci C. Scheider E. Hauser F. Lehmann-Horn C.R. Muller S. Treves Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: Association with central core disease and alteration of calcium homeostasis Hum. Mol. Genet. 10 25 2001 2879-2887
16. N. Monnier N.B. Romero J. Lerale Y. Nivoche D. Qi D.H. MacLennan M. Fardeau J. Lunardi An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor Hum. Mol. Genet. 9 18 2000 2599-2608
17. 2+ release channel function and severe central core disease Proc. Natl. Acad. Sci. U.S.A. 96 7 1999 4164-4169
18. P.C. Scacheri E.P. Hoffman J.D. Fratkin C. Semino-Mora A. Senchak M.R. Davis N.G. Laing V. Vedanarayanan S.H. Subramony A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy Neurology 55 11 2000 1689-1696
19. G. Avila R.T. Dirksen Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor J. Gen. Physiol. 118 3 2001 277-290
20. S. Ducreux F. Zorzato C. Muller C. Sewry F. Muntoni R. Quinlivan G. Restagno T. Girard S. Treves Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease J. Biol. Chem. 279 42 2004 43838-43846
21. A.R. Marks S. Priori M. Memmi K. Kontula P.J. and Laitinen Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia J. Cell. Physiol. 190 1 2002 1-6
22. P.J. Laitinen H. Swan K. Kontula Molecular genetics of exercise-induced polymorphic ventricular tachycardia: Identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphisms Eur. J. Hum. Genet. 11 11 2003 888-891
23. P.J. Laitinen H. Swan K. Piippo M. Viitasalo L. Toivonen K. Kontula Genes, exercise and sudden death: Molecular basis of familial catecholaminergic polymorphic ventricular tachycardia Ann. Med. 36 Suppl. 1 2004 81-86
24. S.G. Priori C. Napolitano M. Memmi B. Colombi F. Drago M. Gasparini L. DeSimone F. Coltorti R. Blosie R. Keegan F.E. Cruz Filho G. Vignati A. Benatar A. DeLogu Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia Circulation 106 1 2002 69-74
25. H. Takeshima S. Nishimura T. Matsumoto H. Ishida K. Kangawa N. Minamino H. Matsuo M. Ueda M. Hanoaka T. Hirose S. Numa Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor Nature 339 1989 439-445
26. 2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum J. Biol. Chem. 265 4 1990 2244-2256
27. 2+ release channel of skeletal muscle sarcoplasmic reticulum (RyR1) Proc. Natl. Acad. Sci. U.S.A. 99 26 2002 16725-16730
28. 2+) release channel of skeletal muscle sarcoplasmic reticulum (ryanodine receptor isoform 1) J. Biol. Chem. 279 36 2004 37566-37574
29. 2+) release channel (ryanodine receptor) activity and conductance Biophys. J. 79 2 2000 828-840
30. B.S. Zhorov D.B. Tikhonov Potassium, sodium, calcium and glutamate-gated channels: Pore architecture and ligand action J. Neurochem. 88 4 2004 782-799
31. M. Zhao P. Li X. Li L. Zhang R.J. Winkfein S.R. Chen Molecular identification of the ryanodine receptor pore-forming segment J. Biol. Chem. 274 37 1999 25971-25974
32. W. Welch S. Rheault D.J. West A.J. Williams A model of the putative pore region of the cardiac ryanodine receptor channel Biophys. J. 87 4 2004 2335-2351
33. M. Samso T. Wagenknecht P.D. Allen Structure of ryanodine receptors revealed by cryoelectron microscopy Biophys. J. 88 2005 383a
34. 2+ concentrations in single skeletal muscle fibers of the frog Can. J. Physiol. Pharmacol. 65 4 1987 681-685
35. C.M. Armstrong F.M. Bezanilla P. Horowicz Twitches in the presence of ethylene glycol bis (-aminoethyl ether)-N,N′-tetracetic acid Biochim. Biophys. Acta 267 3 1972 605-608
36. Y. Jiang A. Lee J. Chen M. Cadene B.T. Chait R. MacKinnon The open pore conformation of potassium channels Nature 417 6888 2002 523-526
37. D.L. Galvan G.A. Mignery Carboxyl-terminal sequences critical for inositol 1,4,5-trisphosphate receptor subunit assembly J. Biol. Chem. 277 50 2002 48248-48260
38. 2+ and monovalent cations and anions J. Biol. Chem. 272 3 1997 1628-1638
39. 2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum J. Biol. Chem. 269 36 1994 22698-22704
40. 2+ release Biochem. J. 291 Pt 3 1993 757-763
41. 2+ sensor J. Biol. Chem. 273 24 1998 14675-14678
42. R.H. Kretsinger Calcium-binding proteins Annu. Rev. Biochem. 45 1976 239-266
43. R.H. Kretsinger Evolution and function of calcium-binding proteins Int. Rev. Cytol. 46 1976 323-393
44. J.D. Fessenden W. Feng I.N. Pessah P.D. Allen Mutational analysis of putative calcium binding motifs within the skeletal ryanodine receptor isoform, RyR1 J. Biol. Chem. 279 51 2004 53028-53035
45. J. Nakai T. Imagawa Y. Hakamat M. Shigekawa H. Takeshima S. Numa Primary structure and functional expression from cDNA of the cardiac ryanodine receptor/calcium release channel FEBS Lett. 271 1-2 1990 169-177
46. Y. Hakamata J. Nakai H. Takeshima K. Imoto Primary structure and distribution of a novel ryanodine receptor/calcium release channel from rabbit brain FEBS Lett. 312 2-3 1992 229-235
47. 2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum J. Biol. Chem. 267 32 1992 23318-23326
48. 2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum J. Biol. Chem. 268 18 1993 13414-13421
49. S.M. Hayek X. Zhu M.B. Bhat J. Zhao H. Takeshima H.H. Valdivia J. Ma Characterization of a calcium-regulation domain of the skeletal-muscle ryanodine receptor Biochem. J. 351 Pt 1 2000 57-65
50. 2+ Release channels (ryanodine receptors) J. Biol. Chem. 274 37 1999 26120-26126
51. 2+ release channel at 14 Å resolution J. Mol. Biol. 345 3 2005 427-431
52. P.J. Lynch R. Krivosic-Horber H. Reyford N. Monnier K. Quane P. Adnet G. Haudecoeur I. Krivosic T. McCarthy J. Lunardi Identification of heterozygous and homozygous individuals with the novel RYR1 mutation Cys35Arg in a large kindred Anesthesiology 86 3 1997 620-626
53. A. Tammaro A. Bracco S. Cozzolino M. Esposito A. Di Martino G. Savoia L. Zeuli G. Piluso S. Aurino V. Nigro Scanning for mutations of the ryanodine receptor (RYR1) gene by denaturing HPLC: Detection of three novel malignant hyperthermia alleles Clin. Chem. 49 5 2003 761-768
54. S. Shepherd F. Ellis J. Halsall P. Hopkins R. Robinson RYR1 mutations in UK central core disease patients: More than just the C-terminal transmembrane region of the RYR1 gene J. Med. Genet. 41 3 2004 e33
55. L. Galli A. Orrico S. Cozzolino V. Pietrini V. Tegazzin V. Sorrentino Mutations in the RYR1 gene in Italian patients at Risk for malignant hyperthermia: Evidence for a cluster of novel mutations in the C-terminal region Cell Calcium 32 3 2002 143-151
56. H. Ruffert D. Olthoff C. Duetrich C.D. Meinecke U.G. Froster Mutation screening in the ryanodine receptor gene (RYR1) in Patients susceptible to maligant hyperthermia who show definite IVCT results: Identification of three novel mutations Acta Anaesthesiol. Scand. 46 2002 692-698
57. E.F. Gillard K. Otsu J. Fujii C. Duff S. de Leon V.K. Khanna B.A. Britt R.G. Worton D.H. MacLennan Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia Genomics 13 4 1992 1247-1254
58. 2+ release channels Am. J. Med. 104 5 1998 470-486
59. 2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease J. Biol. Chem. 272 42 1997 26332-26339
60. K.A. Quane K.E. Keating B.M. Manning J.M. Healy K. Monsieurs J.J. Heffron M. Lehane L. Heytens R. Krivosic-Horber P. Adnet Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: Implications for diagnosis and heterogeneity studies Hum. Mol. Genet. 3 3 1994 471-476
61. H. Rueffert D. Olthoff C. Deutrich R. Schober U.G. Froster A new mutation in the skeletal ryanodine receptor gene (RYR1) is potentially causative of malignant hyperthermia, central core disease, and severe skeletal malformation Am. J. Med. Genet. A 124 3 2004 248-254
62. K.E. Keating L. Giblin P.J. Lynch K.A. Quane M. Lehane J.J. Heffron T.V. McCarthy Detection of a novel mutation in the ryanodine receptor gene in an irish malignant hyperthermia pedigree: Correlation of the IVCT Response with the affected and unaffected haplotypes J. Med. Genet. 34 4 1997 291-296
63. A. Brandt L. Schleithoff K. Jurkat-Rott W. Klingler C. Baur F. Lehmann-Horn Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: Novel mutations and concordance with the in vitro contracture test Hum. Mol. Genet. 8 11 1999 2055-2062
64. K.A. Quane H. Ording K.E. Keating B.M. Manning R. Heine D. Bendixen K. Berg R. Krivosic-Horber F. Lehmann-Horn T. Fagerlund T.V. McCarthy Detection of a novel mutation at amino acid position 614 in the ryanodine receptor in malignant hyperthermia Br. J. Anaesth. 79 3 1997 332-337
65. B. Bauce A. Rampazzo C. Basso A. Bagattin L. Daliento N. Tiso P. Turrini G. Thiene G.A. Danieli A. Nava Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: Early diagnosis of asymptomatic carriers J. Am. Coll. Cardiol. 40 2 2002 341-349
66. N. Tiso D.A. Stephan A. Nava A. Bagattin J.M. Devaney F. Stanchi G. Larderet B. Brahmbhatt K. Brown B. Bauce M. Muriago C. Basso G. Thiene G.A. Danieli A. Rampazzo Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2) Hum. Mol. Genet. 10 3 2001 189-194
67. D.J. Tester D.B. Spoon H.H. Valdivia J.C. Makielski M.J. Ackerman Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: A molecular autopsy of 49 medical examiner/coroner's cases Mayo Clin. Proc. 79 11 2004 1380-1384
68. N. Sambuughin H. Holley S. Muldoon B.W. Brandom A.M. de Bantel J.R. Tobin T.E. Nelson L.G. Goldfarb Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the North American population Anesthesiology 102 3 2005 515-521
69. H. Rueffert D. Olthoff C. Deutrich C.D. Meinecke U.G. Froster Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations Acta Anaesthesiol. Scand. 46 6 2002 692-698
70. B.M. Manning K.A. Quane P.J. Lynch A. Urwyler V. Tegazzin R. Krivosic-Horber K. Censier G. Comi P. Adnet W. Wolz J. Lunardi C.R. Muller T.V. McCarthy Novel mutations at a CpG dinucleotide in the ryanodine receptor in malignant hyperthermia Hum. Mutat. 11 1 1998 45-50
71. B.M. Manning K.A. Quane H. Ording A. Urwyler V. Tegazzin M. Lehane J. O'Halloran E. Hartung L.M. Giblin P.J. Lynch P. Vaughan K. Censier D. Bendixen G. Comi L. Heytens K. Monsieurs T. Fagerlund W. Wolz J.J. Heffron C.R. Muller T.V. McCarthy Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation Am. J. Hum. Genet. 62 3 1998 599-609
72. M. Wehner H. Rueffert F. Koenig D. Olthoff Calcium release from a sarcoplasmic reticulum is facilitated in human myotubes derived from carriers of the ryanodine receptor type 1 mutations Ile2182Phe and Gly2375Ala Genet. Test 7 3 2003 203-211
73. N. Sambuughin Y. Sei K.L. Gallagher H.W. Wyre D. Madsen T.E. Nelson J.E. Fletcher H. Rosenberg S.M. Muldoon North American malignant hyperthermia population: Screening of the ryanodine receptor gene and identification of novel mutations Anesthesiology 95 3 2001 594-599
74. C.L. Marchant F.R. Ellis P.J. Halsall P.M. Hopkins R.L. Robinson Mutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermia Muscle Nerve 30 1 2004 114-117
75. N. Sambuughin S. McWilliams A. de Bantel K. Sivakumar T.E. Nelson Single-amino-acid deletion in the RYR1 gene, associated with malignant hyperthermia susceptibility and unusual contraction phenotype Am. J. Hum. Genet. 69 1 2001 204-208
76. M. Wehner H. Rueffert F. Koenig D. Olthoff Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model Neuromuscul. Disord. 14 7 2004 429-437
77. S. McWilliams T. Nelson R.T. Sudo G. Zapata-Sudo M. Batti N. Sambuughin Novel skeletal muscle ryanodine receptor mutation in a large brazilian family with malignant hyperthermia Clin. Genet. 62 1 2002 80-83
78. V. Barone O. Massa E. Intravaia A. Bracco A. Di Martino V. Tegazzin S. Cozzolino V. Sorrentino Mutation screening of the RYR1 gene and identification of two novel mutations in italian malignant hyperthermia families J. Med. Genet. 36 2 1999 115-118
79. D. Chamley N.A. Pollock K.M. Stowell R.L. Brown Malignant hyperthermia in infancy and identification of novel RYR1 mutation Br. J. Anaesth. 84 4 2000 500-504
80. P.J. Laitinen K.M. Brown K. Piippo H. Swan J.M. Devaney B. Brahmbhatt E.A. Donarum M. Marino N. Tiso M. Viitasalo L. Toivonen D.A. Stephan K. Kontula Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia Circulation 103 4 2001 485-490
81. S.E. Lehnart X.H. Wehrens P.J. Laitinen S.R. Reiken S.X. Deng Z. Cheng D.W. Landry K. Kontula H. Swan A.R. Marks Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak Circulation 109 25 2004 3208-3214
82. Y. Aizawa K. Ueda S. Komura T. Washizuka M. Chinushi N. Inagaki Y. Matsumoto T. Hayashi M. Takahashi N. Nakano M. Yasunami A. Kimura M. Hiraoka A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia Int. J. Cardiol. 99 2 2005 343-345
83. M.R. Davis E. Haan H. Jungbluth C. Sewry K. North F. Muntoni T. Kuntzer P. Lamont A. Bankier P. Tomlinson A. Sanchez P. Walsh L. Nagarajan C. Oley A. Colley A. Gedeon R. Quinlivan J. Dixon D. James C.R. Muller N.G. Laing Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene Neuromuscul. Disord. 13 2 2003 151-157
84. N. Monnier N.B. Romero J. Lerale P. Landrieu Y. Nivoche M. Fardeau J. Lunardi Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor Hum. Mol. Genet. 10 22 2001 2581-2592
85. N.B. Romero N. Monnier L. Viollet A. Cortey M. Chevallay J.P. Leroy J. Lunardi M. Fardeau Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia Brain 126 Pt 11 2003 2341-2349
86. H. Oyamada K. Oguchi N. Saitoh T. Yamazawa K. Hirose Y. Kawana K. Wakatsuki M. Tagami K. Hanaoka M. Endo M. Iino Novel mutations in C-terminal channel region of the ryanodine receptor in malignant hyperthermia patients Jpn. J. Pharmacol. 88 2 2002 159-166
87. R.L. Brown A.N. Pollock K.G. Couchman M. Hodges D.O. Hutchinson R. Waaka P. Lynch T.V. McCarthy K.M. Stowell A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree Hum. Mol. Genet. 9 10 2000 1515-1524
88. H. Jungbluth C.R. Muller B. Halliger-Keller M. Brockington S.C. Brown L. Feng A. Chattopadhyay E. Mercuri A.Y. Manzur A. Ferreiro N.G. Laing M.R. Davis H.P. Roper V. Dubowitz G. Bydder C.A. Sewry F. Muntoni Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores Neurology 59 2 2002 284-287
89. R.M. Quinlivan C.R. Muller M. Davis N.G. Laing G.A. Evans J. Dwyer J. Dove A.P. Roberts C.A. Sewry Central core disease: Clinical, pathological, and genetic features Arch. Dis. Child. 88 12 2003 1051-1055
90. S. Guis D. Figarella-Branger N. Monnier D. Bendahan G. Kozak-Ribbens J.P. Mattei J. Lunardi P.J. Cozzone J.F. Pellissier Multiminicore disease in a family susceptible to malignant hyperthermia: Histology, in vitro contracture tests, and genetic characterization Arch. Neurol. 61 1 2004 106-113
91. A. Ferreiro N. Monnier N.B. Romero J.P. Leroy C. Bonnemann C.A. Haenggeli V. Straub W.D. Voss Y. Nivoche H. Jungbluth A. Lemainque T. Voit J. Lunardi M. Fardeau P.A. Guicheney A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene Ann. Neurol. 51 6 2002 750-759